Why Is Penny Stock Coeptis Therapeutics Gaining Today?
Why Is Penny Stock Coeptis Therapeutics Gaining Today?
This tool helps marketers process large volumes of data, optimize campaigns, improve customer engagement, and streamline operations—key factors for success in the competitive and regulated sectors Coeptis serves.Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) shares traded higher on Thursday after the company announced the completion of its acquisition of the NexGenAI Affiliates Network platform and the launch of Coeptis Technologies.
Coeptis Therapeutics Holdings, Inc.（納斯達克：COEP）的股票在週四上漲，此前公司宣佈已完成對NexGenAI附屬網絡平台的收購以及Coeptis Technologies的推出。
This new division is designed to diversify the company's growth potential, specifically in highly regulated industries like biotech, pharmaceuticals, and multi-level marketing.
這個新部門旨在多樣化公司的增長潛力，特別是在生物技術、製藥和多層次營銷等高度監管的行業中。
The NexGenAI Affiliates Network platform, developed by NexGenAI Solutions Group, is an AI-powered marketing software and robotic process automation (RPA) solution.
NexGenAI附屬網絡平台由NexGenAI解決方案集團開發，是一種基於人工智能的營銷軟體和機器人流程自動化（RPA）解決方案。
This tool helps marketers process large volumes of data, optimize campaigns, improve customer engagement, and streamline operations—key factors for success in the competitive and regulated sectors Coeptis serves.
這個工具幫助營銷人員處理大量數據，優化活動、提高客戶參與度，並簡化運營——這些都是Coeptis所服務的競爭性和受監管板塊成功的關鍵因素。
Also Read: SEALSQ Launches SEALQUANTUM.com Lab To Help Businesses Transition To Quantum-Safe Encryption
另請閱讀：SEALSQ推出SEALQUANTUm.com實驗室，以幫助企業過渡到量子安全加密。
Dave Mehalick, President and CEO of Coeptis, highlighted that integrating these AI-driven tools will be crucial for optimizing marketing strategies and driving measurable results in industries where competition and regulatory challenges are intense.
Coeptis的總裁兼首席執行官Dave Mehalick強調，整合這些以人工智能驅動的工具對於優化營銷策略和推動可衡量的成果至關重要，特別是在競爭和監管挑戰激烈的行業中。
Anshuman Dash, Lead Advisor behind the NexGenAI platform, emphasized that this acquisition aligns with Coeptis' mission to revolutionize marketing and operational efficiency in the biopharmaceutical sector.
NexGenAI平台的首席顧問Anshuman Dash強調，這宗收購與Coeptis的使命一致，即在生物製藥領域徹底改變營銷和運營效率。
By leveraging advanced AI and RPA technologies, Coeptis aims to enhance its service offerings and provide innovative solutions to overcome marketing challenges in the biotech, pharma, and MLM sectors, setting the stage for future growth.
通過利用愛文思控股的人工智能和RPA技術，Coeptis旨在增強其服務提供，併爲克服生物技術、製藥和多層次營銷板塊的營銷挑戰提供創新解決方案，爲未來的增長奠定基礎。
Price Action: COEP shares are trading higher by 45.8% to $0.2070 at last check Thursday.
價格動態：截至上週四最後一次檢查，COEP股票上漲了45.8%，交易價格爲$0.2070。
- Tech Bull Predicts 26% Upside For Apple Stock, Sees 'Golden Era Of Growth' For Cupertino Due To Multi-Year AI-Driven iPhone Upgrade Cycle
- 科技分析師預測蘋果股票將上漲26%，並認爲由於多年由人工智能驅動的iPhone升級週期，庫比蒂諾將迎來「黃金增長時代」。
Photo via Shutterstock.
圖片來自Shutterstock。
譯文內容由第三人軟體翻譯。
